PURPOSE: Although trachoma control programs frequently use the World Health Organization (WHO) simplified grading system for trachoma to monitor the clinical response after repeated mass azithromycin treatments, the programmatic relevance of this evaluation after multiple rounds of antibiotic treatments is unclear. METHODS: Three rounds of annual mass azithromycin were distributed to 12 villages in Ethiopia. Twelve months after the third treatment, children were assessed for follicular trachomatous inflammation (TF) and intense trachomatous inflammation (TI) using the WHO simplified grading system and for ocular chlamydial infection using DNA-based and RNA-based tests. Test characteristics for predicting chlamydial infection were computed assuming a chlamydial RNA-based gold standard. As a secondary analysis, test characteristics were also assessed using a latent class analysis. RESULTS: The prevalence of RNA evidence of ocular chlamydia was 7.1% (95% confidence interval [CI], 2.7-17.4). A DNA-based test and TF had sensitivities of 61.0% (95% CI, 47.1-73.3) and 65.9% (95% CI, 41.6-83.9), specificities of 100% (95% CI, 99.3-100) and 67.5% (95% CI, 61.0-73.5), and positive predictive values of 100% (95% CI, 86.3-100) and 13.4% (95% CI, 5.5-29.3) compared with an RNA-based gold standard. The latent class analysis confirmed that the RNA-based test was a reasonable choice for a gold standard, with a sensitivity of 100% (95% CI, 67.1-100) and specificity of 99.6% (95% CI, 98.1-100). CONCLUSIONS: Basing treatment decisions after mass azithromycin distributions on the WHO simplified grading system will maximize the treatment of infected persons compared with a DNA-based test but will also result in more uninfected persons being treated. The RNA-based test was considerably more sensitive, and almost equivalently specific, compared with a DNA-based test. (ClinicalTrials.gov number, NCT00322972.).
RCT Entities:
PURPOSE: Although trachoma control programs frequently use the World Health Organization (WHO) simplified grading system for trachoma to monitor the clinical response after repeated mass azithromycin treatments, the programmatic relevance of this evaluation after multiple rounds of antibiotic treatments is unclear. METHODS: Three rounds of annual mass azithromycin were distributed to 12 villages in Ethiopia. Twelve months after the third treatment, children were assessed for follicular trachomatous inflammation (TF) and intense trachomatous inflammation (TI) using the WHO simplified grading system and for ocular chlamydial infection using DNA-based and RNA-based tests. Test characteristics for predicting chlamydial infection were computed assuming a chlamydial RNA-based gold standard. As a secondary analysis, test characteristics were also assessed using a latent class analysis. RESULTS: The prevalence of RNA evidence of ocular chlamydia was 7.1% (95% confidence interval [CI], 2.7-17.4). A DNA-based test and TF had sensitivities of 61.0% (95% CI, 47.1-73.3) and 65.9% (95% CI, 41.6-83.9), specificities of 100% (95% CI, 99.3-100) and 67.5% (95% CI, 61.0-73.5), and positive predictive values of 100% (95% CI, 86.3-100) and 13.4% (95% CI, 5.5-29.3) compared with an RNA-based gold standard. The latent class analysis confirmed that the RNA-based test was a reasonable choice for a gold standard, with a sensitivity of 100% (95% CI, 67.1-100) and specificity of 99.6% (95% CI, 98.1-100). CONCLUSIONS: Basing treatment decisions after mass azithromycin distributions on the WHO simplified grading system will maximize the treatment of infected persons compared with a DNA-based test but will also result in more uninfected persons being treated. The RNA-based test was considerably more sensitive, and almost equivalently specific, compared with a DNA-based test. (ClinicalTrials.gov number, NCT00322972.).
Authors: Peter Lowe; Peter O'Loughlin; Kathryn Evans; Michael White; Paul B Bartley; Renu Vohra Journal: J Clin Microbiol Date: 2006-07 Impact factor: 5.948
Authors: Mariko Bird; Chandler R Dawson; Julius S Schachter; Yinghui Miao; Ahmed Shama; Ahmed Osman; Ahmad Bassem; Thomas M Lietman Journal: J Infect Dis Date: 2003-04-30 Impact factor: 5.226
Authors: Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos Journal: J Clin Microbiol Date: 2009-04-22 Impact factor: 5.948
Authors: Jenafir I House; Berhan Ayele; Travis C Porco; Zhaoxia Zhou; Kevin C Hong; Teshome Gebre; Kathryn J Ray; Jeremy D Keenan; Nicole E Stoller; John P Whitcher; Bruce D Gaynor; Paul M Emerson; Thomas M Lietman Journal: Lancet Date: 2009-03-28 Impact factor: 79.321
Authors: M Chernesky; D Jang; E Portillo; S Chong; M Smieja; K Luinstra; A Petrich; C Macritchie; R Ewert; B Hayhoe; A Sarabia; F Thompson Journal: J Clin Microbiol Date: 2007-05-30 Impact factor: 5.948
Authors: Emily S West; Beatriz Munoz; Harran Mkocha; Martin J Holland; Aura Aguirre; Anthony W Solomon; Robin Bailey; Allen Foster; David Mabey; Sheila K West Journal: Invest Ophthalmol Vis Sci Date: 2005-01 Impact factor: 4.799
Authors: Sheila K West; Beatriz Munoz; Harran Mkocha; Martin J Holland; Aura Aguirre; Anthony W Solomon; Allen Foster; Robin L Bailey; David C W Mabey Journal: Lancet Date: 2005-10-08 Impact factor: 79.321
Authors: Meron Haile; Zerihun Tadesse; Sintayehu Gebreselassie; Berhan Ayele; Teshome Gebre; Sun N Yu; Nicole E Stoller; Bruce D Gaynor; Travis C Porco; Paul M Emerson; Thomas M Lietman; Jeremy D Keenan Journal: Am J Trop Med Hyg Date: 2013-09-03 Impact factor: 2.345
Authors: Artemis Koukounari; Irini Moustaki; Nicholas C Grassly; Isobel M Blake; María-Gloria Basáñez; Manoj Gambhir; David C W Mabey; Robin L Bailey; Matthew J Burton; Anthony W Solomon; Christl A Donnelly Journal: Am J Epidemiol Date: 2013-04-01 Impact factor: 4.897
Authors: Jennifer R Evans; Anthony W Solomon; Rahul Kumar; Ángela Perez; Balendra P Singh; Rajat Mohan Srivastava; Emma Harding-Esch Journal: Cochrane Database Syst Rev Date: 2019-09-26
Authors: Fengchen Liu; Travis C Porco; Abdou Amza; Boubacar Kadri; Baido Nassirou; Sheila K West; Robin L Bailey; Jeremy D Keenan; Thomas M Lietman Journal: Parasit Vectors Date: 2015-10-22 Impact factor: 3.876
Authors: Chrissy H Roberts; Anna Last; Sandra Molina-Gonzalez; Eunice Cassama; Robert Butcher; Meno Nabicassa; Elizabeth McCarthy; Sarah E Burr; David C Mabey; Robin L Bailey; Martin J Holland Journal: J Clin Microbiol Date: 2013-05-01 Impact factor: 5.948